The Centers for Medicare & Medicaid Services this week awarded 14 states and the District of Columbia planning grants totaling $48.5 million to increase access to evidence-based treatment and recovery services for Medicaid patients with substance use disorders. Alabama, Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Michigan, Nevada, New Mexico, Rhode Island, Virginia, Washington and West Virginia will use the grants to assess state needs, recruit and train providers, and improve reimbursement to expand treatment capacity. Section 1003 of the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorized the planning grants for a demonstration project to increase Medicaid provider capacity to treat SUDs. CMS will select up to five of the states to receive an enhanced federal matching rate for SUD services for three years under the project.

Related News Articles

Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
The Centers for Medicare & Medicaid Services Sept. 9 issued preliminary guidance regarding the implementation of certain state-directed payment provisions…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The AHA and other national hospital organizations Sept. 5 urged Senate and House leadership to act on preventing Medicaid Disproportionate Share Hospital…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
The Centers for Medicare & Medicaid Services today announced a nationwide initiative aimed at reinforcing eligibility standards for Medicaid and the…